Evidence map›Paper›PMID 24719228›Full record

ArticleRheumatology international2014

Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis.

I Lima, R C Oliveira, M S Cabral, A Atta, S Marchi, E Reis, M G Reis, L Barbosa, M B Santiago

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

I LimaEscola Bahiana de Medicina e Saúde Pública, Rua Frei Henrique, 08, Nazaré, Salvador, Bahia, CEP 40.000-000, Brazil.
R C Oliveira
M S Cabral
A Atta
S Marchi
E Reis
M G Reis
L Barbosa
M B Santiago
Fundação de Amparo à Pesquisa do Estado da Bahia · BREscola Bahiana de Medicina e Saúde Pública · BRUniversidade Federal da Bahia · BRHospital Ana Nery · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed to intracellular components of neutrophils and are present in several vasculitic syndromes. Recently, these autoantibodies have been described in other autoimmune disorders as well as in infectious diseases such as tuberculosis (TB). As there are some clinical similarities between TB and granulomatosis with polyangiitis, we searched for ANCA in a group of patients with proven TB. Patients with TB confirmed by chest X-ray and sputum bacilloscopy either before or within 30 days after beginning treatment were included in this study. Anti-MPO and anti-PR3 antibodies were studied using well-standardized ELISA kits (INOVA Diagnostics, Inc.). ANCA were also investigated by indirect immunofluorescence (IIF). Fifty TB patients (26 females, mean age 47.34 ± 17 years) were enrolled in the present study. No patient tested positive for ANCA by IIF, or anti-MPO or anti-PR3 antibodies by ELISA. Although previous studies have shown the presence of ANCA in some infectious diseases, the findings of the present study demonstrated the absence of such antibodies in TB. The discrepancy in the prevalence of ANCA in TB among different studies may be attributed to methodological factors and/or the genetic background of the studied populations.

Indexed as

AdultAntibodies, Antineutrophil CytoplasmicAntitubercular AgentsBiomarkersBrazilEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueHumansMaleMiddle AgedMycobacterium tuberculosisMyeloblastinPeroxidasePredictive Value of TestsSputumAntibodies, Antineutrophil CytoplasmicAntitubercular AgentsBiomarkersMyeloblastinPeroxidase

Identifiers

PMID24719228
OpenAlexW1974868280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.